The Foodand DrugAdministration could now revoke over-the-counter designations for phenylephrine, an active ingredient in Benadryl and Sudafed. Pfizer’s COVID-19 pill: Here’s the latest on ...
today announced that the U.S. Foodand DrugAdministration (FDA) has issued a complete response letter (CRL), dated October 22, 2024, for the ketamine Abbreviated New Drug Application, which ...
to the U.S. Foodand DrugAdministration (FDA) for vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy (ATTR-CM). Vutrisiran ...